1 authorship bernard lo, m.d. august 23 and september 2, 2010
Post on 20-Dec-2015
214 views
TRANSCRIPT
![Page 1: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/1.jpg)
1
Authorship
Bernard Lo, M.D.
August 23 and September 2, 2010
![Page 2: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/2.jpg)
2
Survey of UCSF fellows
Omitted as author 20%
Co-author didn’t deserve it 38%
Asked to make someone author who
didn’t deserve it 37%
![Page 3: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/3.jpg)
3
Case 1: Prior agreements fail
Participants enrolled, data collected
and entered into statistical program
First author not analyzing data or
writing paper
You want to take lead, get paper out
![Page 4: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/4.jpg)
4
Case 1: Prior agreements fail
What would you do? Send an ultimatum to your colleague Get your mentor to pressure him Forget about the project and move on Not sure
![Page 5: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/5.jpg)
5
Case 2: Added author
Division chief asks to be author
Comments in seminars and on abstract
Not participate in design or analysis
![Page 6: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/6.jpg)
6
Case 2: Added author
What would you do? Hold your nose and do it Ask your department chair to intervene Refuse and stand up for your principles Forget about the project and move on Not sure
![Page 7: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/7.jpg)
7
Outline of session
Criteria for authorship
Problems with authorship
Practical dilemmas
![Page 8: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/8.jpg)
8
Why have authorship?
Recognition Job, grants, promotions
Accountability Vouch for results and conclusions Prevent fabrication, fraud, plagiarism
![Page 9: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/9.jpg)
9
Criteria for authorship
Conception and design or data
analysis and interpretation, AND
Drafting or revising article for
important intellectual content, AND
Approving final manuscript
![Page 10: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/10.jpg)
10
Criteria for authorship
Not merely
Funding or equipment
Collection of data
Supervision of research group
![Page 11: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/11.jpg)
![Page 12: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/12.jpg)
12
Implications of authorship
Take responsibility for at least one
component
Identify who is responsible for each
component
Confidence in co-authors ability and
integrity
![Page 13: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/13.jpg)
13
Problems with authorship
1. Publish articles that shouldn’t be
published False, fabricated data Duplicate publications
![Page 14: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/14.jpg)
14
Duplicate publication
Articles in systematic reviews 1234
Duplicate 103 (8%)
No cross reference 63%
Translations 12%
JAMA 2004; 291: 974
![Page 15: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/15.jpg)
15
Types of duplication
Identical sample and outcomes
Combine several articles
Report different outcomes on sample
New data added to preliminary article
Part of larger trial, same outcomes
![Page 16: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/16.jpg)
16
What is wrong with multiple publications?
Inefficient transfer of information
Bias in evidence base for systematic
reviews
![Page 17: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/17.jpg)
17
Problems with authorship
2. Fail to publish articles that should be Negative results
3. Too many authors = honorary authors People listed who shouldn’t be
4. Too few authors = ghost authors People omitted who should be authors
![Page 18: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/18.jpg)
18
Advantage study (2003)
Randomized trial of 5557 patients
Refecoxib vs. naproxen
Discontinue Rx for GI reasons: 5.9%
vs. 8.1%
![Page 19: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/19.jpg)
19
Advantage study
MIs: 5 on rofecoxib vs. 1 on naproxen 3 additional rofecoxib deaths not reported
![Page 20: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/20.jpg)
20
Statement by 1st author
“Merck designed the trial, paid for the trial, ran
the trial. . . Merck came to me after the study
was completed and said, ‘We want your help
to work on the paper.’ The initial paper was
written at Merck, and then was sent to me for
editing”
![Page 21: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/21.jpg)
21
Requirements for industry-sponsored research
Full responsibility for trial Design of study Access to data
• Independent statistician
Data analysis
Control over publication Including data detrimental to product
![Page 22: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/22.jpg)
22
Requirements for industry-sponsored research
Disclose financial relationships Including payment for writing
![Page 23: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/23.jpg)
23
Ghostwriting
Asked by medical education company
to write a review paper on interactions
between warfarin and dietary
supplements sponsored by drug
company
JGIM 2005; 20: 546
![Page 24: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/24.jpg)
24
Ghostwriting
Received draft article, with name on
title page
Company developing oral
anticoagulant No mention of product Biased against warfarin
![Page 25: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/25.jpg)
25
Ghostwriting
Later asked to review same paper No mention of ghost author No mention of drug company sponsorship
![Page 26: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/26.jpg)
Are these isolated cases?
26
![Page 27: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/27.jpg)
27
Problematic authorship
Honorary authors 21%
Ghost authors 13%
Ghosts acknowledged 0%
JAMA 1998; 280:222
![Page 28: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/28.jpg)
28
Problematic authorship
No substantial contributions26%
Provided subjects, materials,
lab, technical assistance 58%
Collected data 25%
JAMA 1994; 271: 438
![Page 29: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/29.jpg)
29
Preventing ghost authorship
All persons who had input into writing
must be author or acknowledged
All persons named as authors or
acknowledged must complete financial
disclosure
![Page 30: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/30.jpg)
30
Problems with authorship
5. Authors in wrong positions
![Page 31: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/31.jpg)
31
Who’s on second?
Less prestige than first
Middle authors contribute even less
Last author often senior
Not cited after 6th
![Page 32: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/32.jpg)
32
Survey of department chairs
Fictitious article and authors
Infer author’s contributions
Epidemiology 2004; 15; 125
![Page 33: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/33.jpg)
33
Contributions of authors
“Little idea of roles of any author”
If corresponding author, more credit
![Page 34: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/34.jpg)
34
Documentation of authorship
Describe specific contributions In manuscript In promotion packet
![Page 35: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/35.jpg)
Relationships among authors
35
![Page 36: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/36.jpg)
36
Paper on predictive model for HIV genotyping
1. Medical student
2. Former industry scientist, now at FDA Lawsuit against former company
3. Biostatistician
4. Programmer
5. You
![Page 37: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/37.jpg)
37
2nd author
Demanding and persistent in opinions
Revisions a “marathon”
Decisions not to accept his advice =
disregard his opinion “Accusatory and insulting”
![Page 38: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/38.jpg)
38
Paper has 4 rejections
2nd author wants to reframe the paper More on advances in predictive models
![Page 39: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/39.jpg)
39
Concerns of senior author
Get the article published somewhere Want to influence practice guidelines
Get medical student a publication for
internship applications
Minimize time and hassle
![Page 40: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/40.jpg)
40
Plan
One round of discussions
Senior author writes revision
Give authors option of accepting final
draft or withdrawing as author
![Page 41: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/41.jpg)
Suggestions
Like “problem patient” Listen to concerns and expectations Address emotional issues explicitly Set boundaries Get agreement on process
Dissenting section of paper An alternative interpretation …
41
![Page 42: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/42.jpg)
Suggestions
Mediation
42
![Page 43: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/43.jpg)
43
Concussions in NFL players
Retrospective review of data from team
physicians
Return to play not associated with
increased risk of second concussion
![Page 44: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/44.jpg)
44
Conclusion
“Might be safe for college/high school
football players to be cleared to return
to play on the same day as the injury”
“Keep an open mind to possibility that
present analysis of professional
football players may have relevance to
college and high school players.”
![Page 45: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/45.jpg)
45
Dispute among 5 authors
Two disagreed
One said passage added without her
knowledge
![Page 46: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/46.jpg)
46
Lead author
Proofs were sent to each author No need to point out new passage
“If people who are not scientists or
physicians are misinterpreting it, that
is not the responsibility of those who
wrote it.”
![Page 47: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/47.jpg)
47
Case 1: Prior agreements fail
What would you do? Send an ultimatum to your colleague Get your mentor to pressure him Forget about the project and move on Not sure
![Page 48: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/48.jpg)
48
Excuses
It’s in the pipeline
It’s next in the pipeline
BMJ 1994; 309: 1739
![Page 49: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/49.jpg)
49
Excuses
I’m reanalyzing the data
The data are on a Windows computer
I can’t find the right statistical test to
prove it worked
![Page 50: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/50.jpg)
50
Pragmatic concerns
Power differences
Future repercussions
Is it worth the hassle?
Can you live with yourself?
![Page 51: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/51.jpg)
51
Just do it, diplomatically
“I know you’re very busy. I’m willing to
take over as 1st author and write a
draft.”
“If I haven’t heard in 3 weeks, I’ll
assume you’re too busy to be first
author.”
![Page 52: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/52.jpg)
52
Case 2: Added author
What would you do? Hold your nose and do it Refuse and stand up for your principles Ask your department chair to intervene
![Page 53: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/53.jpg)
53
Just say no, diplomatically
“The journal insists that all authors
sign that they have met a list of
requirements. I would feel very
awkward signing this. I’d like your
permission to give you a big thank you
in the acknowledgments.”
![Page 54: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/54.jpg)
Emotional impact of authorship disputes
After disputes commonly feel:
Angry
Hurt
Taken advantage of
54
![Page 55: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010](https://reader038.vdocuments.us/reader038/viewer/2022103123/56649d415503460f94a1bd24/html5/thumbnails/55.jpg)
55
Take home points
Be explicit about authorship positions
and responsibilities
Spell out arrangements in advance